XML 50 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Basis of Presentation and Summary of Significant Accounting Policies - Anti-dilutive Share Equivalents (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 9,807,474 11,617,078
Options to purchase Common Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,860,507 1,015,418
Warrants to purchase Common Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 5,260,992 10,589,482
Restricted Stock Units    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 491 11,301
Series A Convertible Preferred Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 877 877
Series E Convertible Preferred Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 2,684,607 0